Coronary interventions Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes Azzalini L, Poletti E, Ayoub M, Ojeda S, Zivelonghi C, La Manna A, Bellini B, Lostalo A, Luque A, Venuti G, Montorfano M, Agostoni P, Pan M, Carlino M, Mashayekhi K October 4, 2019 | 10.4244/EIJ-D-19-00282
Peripheral interventions Percutaneous reintervention in patients with aortic coarctation stenting at an early age. Pan M, Ojeda S, Hidalgo F, de Lezo J, Lostalo A, Mazuelos F, Segura J, Pericet C, Luque A, Gonzalez R, Fernandez A, Gomez E, Romero M March 26, 2019 | 10.4244/EIJ-D-18-00923
Impact of crossing strategy on midterm outcomes following percutaneous revascularisation of coronary chronic total occlusions Azzalini L, Dautov R, Brilakis E, Ojeda S, Benincasa S, Bellini B, Karatasakis A, Chavarria J, Rangan B, Pan M, Carlino M, Colombo A, Rinfret S October 20, 2017 | 10.4244/EIJ-D-16-01010
Coronary interventions Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R June 20, 2017 | 10.4244/EIJ-D-16-00253
Coronary interventions Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry de la Torre Hernandez J, Rumoroso J-R, Subinas A, Gonzalo N, Ojeda S, Pan M, Yuste V, Suarez A, Hernandez F, Teruel L, Moreu J, Cubero J, Cascon J, Vinhas H, Lozano I, Moreiras J, de Prado A, Goicolea J, Escaned J June 2, 2017 | 10.4244/EIJ-D-16-00764
Coronary interventions Patency of coronary side branches covered by an everolimus-eluting bioresorbable vascular scaffold: clinical outcomes and computed tomography scan follow-up Ojeda S, Pan M, de Lezo J, Martin P, Mazuelos F, Romero M, Novoa J, Espejo S, Segura J, Morenate C, Medina A, de Lezo J February 12, 2016 | 10.4244/EIJV11I11A250
New issue Discover the Special Edition on valvular heart disease prepared for PCR London Valves (3D-TEE model - Optimal implantation) November 15, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial Medical device regulation in Europe – what is changing and how can I become more involved? October 18, 2019